Our data showed that PIK3IP1, the suppressor of PI3K/AKT/mTOR signaling, is significantly downregulated in AML cells and that PIK3IP is significantly elevated upon the combination of DZNeP with Ven. This evidence concerns the gene MTOR and acute myeloid leukemia.